Spain on Sept. 7 has authorized a third dose of COVID-19 vaccines for some severely immunosuppressed people who are likely to have an inadequate immune response to the conventional two-dose vaccination scheme.
In a statement after a meeting, the Public Health Commission of Spain’s Health Ministry announced that it has approved a third dose for patients with solid organ transplants, blood stem cell recipients, and those taking monoclonal antibodies, which are used by patients with some cancers and multiple sclerosis.
The third dose must be administered at least 28 days after the previous dose, except for patients currently taking monoclonal antibodies who should receive the dose six months after the end of their therapy, the Commission said.
The Commission also said that preferably the same type of vaccine is to be used.
The Commission did not say how many people could get the shots.
The decision was based on the recommendations of the Vaccine Report and the COVID-19 Vaccination Technical Working Group (GTT), according to the Commission.
However, the Vaccine Report and GTT noted that there is currently “no solid data” to support administering the booster shots to the general population.
“In addition, they have stressed that there is still no vaccine with the indication of booster doses in its technical data sheet,” the Commission said.
The announcement comes days after the United Kingdom announced that it will give a third dose to severely immunosuppressed people.
Last month, the World Health Organization has called for a moratorium on COVID-19 booster shots until “at least the end of September” to allow more doses to be available for vulnerable people in low-income countries.
© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.